We found that treatment with Cdc20 inhibitors, such as apcin and Taxol, significantly reduced TPD52 polyubiquitination and degradation and proved to have an excellent synergistic effect with tunicamycin in cancer treatment. This evidence concerns the gene CDC20 and cancer.